Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.

Kevin J FreiseMartin DunbarAksana K JonesDavid HoffmanSari L Heitner EnschedeShekman WongAhmed Hamed Salem

Published in: Cancer chemotherapy and pharmacology (2016)

Venetoclax does not prolong QTc interval even at supra-therapeutic doses, and there is no relationship between venetoclax concentrations and QTc interval.

Keyphrases

chronic lymphocytic leukemia
drug induced